Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Inducible phase separation of GSK3α as a mechanism for asparaginase resistance in acute leukemias
    Meeting Abstract

    Hinze, L.; Schreek, S.; Zeug, A.; Ponimaskin, E.; Labrosse, R.; Degar, J.; Chiosis, G.; Pai, S. Y.; Stevenson, K. E.; Neuberg, D. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Timing the initiation of multiple myeloma
    Meeting Abstract

    Maura, F.; Rustad, E. H.; Bolli, N.; Yellapantula, V.; Leongamornlert, D.; Nadeu, F.; Angelopoulos, N.; Dawson, K. J.; Mitchell, T. J.; Osborne, R. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
    Journal Article

    Sher, F.; Hossain, M.; Seruggia, D.; Schoonenberg, V. A. C.; Yao, Q.; Cifani, P.; Dassama, L. M. K.; Cole, M. A.; Ren, C.; Vinjamur, D. S.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Markov models of functional dynamics of histone methyltransferases by millisecond-timescale molecular simulation and chemical probing
    Meeting Abstract

    Wiewiora, R.; Chen, S.; Luo, M.; Chodera, J.
    Abstracts of Papers of the American Chemical Society (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Growth factors stimulate anabolic metabolism by directing nutrient uptake
    Review

    Thompson, C. B.; Bielska, A. A.
    Journal of Biological Chemistry (2019)

    Fulltext@MSK | Save
  • Donor HLA-E status associates with disease-free survival and transplant-related mortality after non in vivo T cell-depleted HSCT for acute leukemia
    Journal Article

    Tsamadou, C.; Fürst, D.; Wang, T.; He, N.; Lee, S. J.; Spellman, S. R.; Fleischhauer, K.; Hsu, K. C.; Paczesny, S.; Verneris, M. R.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save